Popular
HomeOur PositionResults of treatmentStatisticsPublications
Extra RequirementsTip of the DayI want to knowContact Information

COMPARATIVE CHARACTERISTICS OF THE NEOHALENIC MEDICATIONS
(by main and side effects)

MEDICATION
(trade mark)
PHARMACEUTICAL FORM DOSAGE
(dayly dose)
EFFECT TOXYCITY
(international 5 gr. scale)
ACCESSIBILITY
1 2 3 4
Tropofin amp. every 6 hours 4 4 1 5 2 3
Metacistin amp. every 12 hours 3 4 5 2 3 2
Fitomaks tab., supp. individual scheme 1 1 4 4 1 1
Fitor tab., supp. individual scheme 1 1 3 4 1 1
Flaraxin sm. bottle once a day 4 3 5 5 0-1 3
Fitotrol sm. bottles, supp. once a day 5 3 2 3 0-1 5
Salbifit caps., supp. individual scheme 2 4 5 3 3 1
Alometastat amp. once a day 4 5 2 2 4 1
Giniprofit supp., dragee individual scheme 2 3 4 5 0-1 1
Theomitosit amp. once per 3 days 5 4 1 3 1-2 4
Multiimmun sm. bottles., supp. once a day 2 3 5 5 0 4
Taylecitin sm. bottles, tab. twice a day 4 5 1 4 2 5
Lisophitostat amp., supp. once a day 3 5 5 3 1-2 1
Flegaxin sm. bottles, amp. once per 5 days 3 3 5 5 0-1 5

For comparison:

Traditional polychemotherapy 1-2 4 (by WHO's 5 grade scale: 0 to 4)

 

Comments: Effect:

1st column -

antimitotic

2nd column -

antimetastatic

3rd column -

immunomodulation

4th column -

metabolic

I. Pharmacological activity and clinical effects:
1 - low, 2 - below average, 3 - average, 4 - above average, 5 - high
II. Accessibility of the medications on the international market (by price):
1 - significantly below average, 2 - below average, 3 - average price in group, 4 - above average, 5 - significantly above average.

Analysis of the results of oncologic diseased people treatment and the effectiveness and toxicity of the preparations

Type of tumor by morphological characteristics:
Stomachbreast (mammary gland)lungsintestines.

Pharmacological characteristics of used phytomedications.

Results of treatment neoplasms of different locations
(only IV stage)

Disease Results of treatment
After 1st course After 2nd course After 3 and more courses
Total improvement without changes Total improvement without changes Total improvement without changes
Units   abs. % abs. %   abs. % abs. %   abs. % abs. %
Stomach cancer 28 11 39.2 17 60.7 9 7 77 2 23 5 3 60 2 40
Pancreas cancer 11 4 36 7 64 8 5 63 3 37 7 7 100 - -
Breast cancer 97 57 58.1 41 41.8 69 40 57.9 29 42 29 16 55.1 13 44.8
Larynx cancer 10 6 60 4 40 2 2 100 - - 6 4 66 2 33
Bronchi cancer 14 8 57 6 43 8 4 50 4 50 9 8 88 1 22
Lungs cancer 27 12 44.4 15 55.5 23 11 47.8 12 52.1 12 9 75 3 25
Colon cancer 14 4 28.5 10 71.4 6 2 33.3 4 66.6 5 1 20 4 80
Prostate cancer 7 3 43 4 57 - - - - - 1 1 100 -
Bladder cancer 3 2 67 1 33 1 1 100 - - 3 2 67 1 33
Kidneys cancer 2 1 50 1 50 2 2 100 - - 2 1 50 1 50
Lymphatic system cancer 5 3 60 2 40 5 2 40 3 60 5 4 80 1 20
Thyroid gland cancer 2 1 100 1 100 - - - - - 1 1 100 - -
Brain cancer 5 3 60 2 40 1 1 100 - - 5 4 80 1 20
Melanoma 4 3 75 1 25 1 1 100 - - 6 5 83 1 17

Stomach

Stage of the cancer Results of treatment
After 1st course After 2nd course After 3 and more courses
improvement without changes Total improvement without changes Total improvement without changes
Number abs. % abs. %   abs. % abs. %   abs. % abs. %
Incl. Total 24 18 75 6 25 14 10 71 4 29 14 12 86 2 14
III st.

1
1 100 - - 1 1 100 - - - - - - -
IV st.

23
17 74 6 26 13 9 69.2 4 30.8 14 12 85.7 2 14.3

Top of page

Breast

Stage of the cancer Results of treatment
After 1st course After 2nd course After 3 and more courses
improvement without changes Total improvement without changes Total improvement without changes
Number abs. % abs. %   abs. % abs. %   abs. % abs. %
Incl. Total 53 36 68 17 32 44 33 75 11 25 34 26 76 8 24
III st.

4
4 100 - - 1 1 100 - - - - - - -
IV st.

49
32 65.3 17 34.7 43 32 74.4 11 25.6 33 25 75.8 8 24.2

Top of page

Lungs

Stage of the cancer Results of treatment
After 1st course After 2nd course After 3 and more courses
improvement without changes Total improvement without changes Total improvement without changes
Number abs. % abs. %   abs. % abs. %   abs. % abs. %
Incl. Total 48 31 65 17 35 39 30 77 9 23 19 15 79 4 21
III st.

2
1 50 1 50 1 - - 1 100 - - - - -
IV st.

46
30 65.2 16 34.8 38 30 78.9 8 21 19 15 79 4 21

Top of page

Colon

Stage of the cancer Results of treatment
After 1st course After 2nd course After 3 and more courses
improvement without changes Total improvement without changes Total improvement without changes
Number abs. % abs. %   abs. % abs. %   abs. % abs. %
Incl. Total 39 24 62 15 38 21 17 81 4 19 19 16 84 3 16
III st.

2
2 100 - - 1 1 100 - - - - - - -
IV st.

37
22 59.5 15 40.5 20 16 80 4 20 19 16 84.2 3 15.8

Top of page

Toxicity and efficiency of used phytomedications in comparison with classical chemotherapeutic medications.

Medication Effect Toxicity
0 1 2 3 4

Phyto-
medications
 
90 - 100 0 - 1 0 - 1 0 - 1 0 - 1 0 - 1
Nitrozo-
methyl
urea
15 - 20 2 - 3 2 - 3 2 - 3 2 - 3 2 - 3
Poly-
chemo-
therapy
20 - 30 2 - 3 2 - 3 2 - 3 3 - 3 3 - 4

Comment: The table is developed accounting the clinical data of effectiveness and toxic rates of methods according to the test table:
N.I.Perevodchikova, Antitumor therapy, M., "Medicina" 1986, p. 36 - 37, 166.

Make conclusions by yourself.

Top of page

 

Copyright 2001, Popular Co. Ltd. All Rights Reserved
Privacy Statement | Client Agreement | Tell-a-Friend

suggestions for webmaster dr.dovnar@gmail.com